Nuplex agrees to buy Med-Chem ingredient business

Nuplex Industries, a specialty chemicals manufacturer, agreed to buy the ingredients business of Med-Chem group, saying the purchase will lift earnings for its Specialties unit in the next 12 months.

The price wasn’t disclosed. Med-Chem is a closely held group which also distributes medical and surgical equipment. Med-Chem Surgical will remain with the current owners, Nuplex said. The group is owned by Geoffrey Walker and Graham Carey, according to the Companies Office.

The acquisition will lift profit at Nuplex’s Specialities division by 15% for the first 12 months, the company said in a statement today. Employees in Australia and New Zealand who are directly related to sales and customer service will join Nuplex.

“This acquisition is consistent with our strategy to grow in the Australasian high compliance market sectors,” said managing director John Hirst. It will “continue our focus on functional materials where Nuplex’s in-house technical and compliance resources add value to distributed raw materials.”

Med-Chem has “a strong market position as a supplier to sophisticated segments of the Australian and New Zealand food, pharmaceutical and personal care manufacturing industries,” Hirst said.

Shares of Nuplex rose 1 cent to $3.32 yesterday and have gained about 13% this year while the NZX 50 Index has slipped about 1%.

Businesswire.co.nz

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Printable version

Related News

Nuplex enters Russian joint venture
Nuplex shares plunge 7.8% after profit warning
Nuplex gains regulatory approval for Viverso purchase
Nuplex may replace some bank debt with first issue of bonds in US private placement market
Nuplex to buy Bayer MaterialScience's Viverso, forecasts 10% earnings growth
Nuplex bows to shareholder pressure, withdraws director fee hike proposal
Nuplex directors ask for shareholders for 33% pay rise
Nuplex pays A$23.5 mln for Acquo Masterbatch
Nuplex full year profit up 7.5 pct
Daily ShareChat: Nuplex

Get quotes for Nuplex Industries Limited Ordinary Share (NPX)

NZX Annoucements for NPX